These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3094010)

  • 41. Antisera to the variable region of ras oncogene proteins, and specific detection of H-ras expression in an experimental model of chemical carcinogenesis.
    Bizub D; Heimer EP; Felix A; Chizzonite R; Wood A; Skalka AM; Slater D; Aldrich TH; Furth ME
    Oncogene; 1987 May; 1(2):131-42. PubMed ID: 2449645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular heterogeneity of the smg-21/Krev-1/rap1 proteins, a GTP-binding protein having the same effector domain as ras p21s, in bovine aortic smooth muscle membranes.
    Kawata M; Kawahara Y; Sunako M; Araki S; Koide M; Tsuda T; Fukuzaki H; Takai Y
    Oncogene; 1991 May; 6(5):841-8. PubMed ID: 1646988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of ras GTP-binding mutants using an in situ colony-binding assay.
    Feig LA; Pan BT; Roberts TM; Cooper GM
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4607-11. PubMed ID: 3088563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.
    Peace DJ; Chen W; Nelson H; Cheever MA
    J Immunol; 1991 Mar; 146(6):2059-65. PubMed ID: 2005390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
    Herlyn M; Steplewski Z; Atkinson BF; Ernst CS; Koprowski H
    Hybridoma; 1982; 1(4):403-11. PubMed ID: 6765323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.
    Hollingsworth MA; Rebellato LM; Moore JW; Finn OJ; Metzgar RS
    Cancer Res; 1986 May; 46(5):2482-7. PubMed ID: 3697988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
    Watatani M; Perantoni AO; Reed CD; Enomoto T; Wenk ML; Rice JM
    Cancer Res; 1989 Mar; 49(5):1103-9. PubMed ID: 2645046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation, characterization and properties of monoclonal antibodies against intact H-ras p21 proteins.
    Sorrentino V; Nebreda AR; Alonso T; Santos E
    Oncogene; 1989 Feb; 4(2):215-22. PubMed ID: 2467247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
    Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
    Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene.
    Bos JL; Verlaan-de Vries M; Marshall CJ; Veeneman GH; van Boom JH; van der Eb AJ
    Nucleic Acids Res; 1986 Feb; 14(3):1209-17. PubMed ID: 3951985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
    Kantor RR; Ng AK; Giacomini P; Ferrone S
    Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis.
    Sinha S; Webber C; Marshall CJ; Knowles MA; Proctor A; Barrass NC; Neal GE
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3673-7. PubMed ID: 3287372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
    Tanaka T; Slamon DJ; Cline MJ
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3400-4. PubMed ID: 3858828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of two major activating lesions on the structure and conformation of human ras oncogene products.
    Srivastava SK; Yuasa Y; Reynolds SH; Aaronson SA
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):38-42. PubMed ID: 3918304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the human c-myc protein using antibodies prepared against synthetic peptides.
    Evan GI; Hancock DC; Littlewood T; Pauza CD
    Ciba Found Symp; 1986; 119():245-63. PubMed ID: 3525040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene.
    Valenzuela DM; Groffen J
    Nucleic Acids Res; 1986 Jan; 14(2):843-52. PubMed ID: 3945555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dimensional single-cell cancer biology.
    Irish JM; Doxie DB
    Curr Top Microbiol Immunol; 2014; 377():1-21. PubMed ID: 24671264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.